For example, the inhibition of Notch activation through γ-secretase inhibitors is reported to reduce the CD133-positive GBM cell population in vitro and to reduce tumorigenicity of pretreated brain tumor cells subcutaneously injected in athymic mice [37]. Here, PROM1 is linked to glioblastoma.